Modulation of PD-L1 expression by standard therapy in head and neck cancer cell lines and exosomes

Although checkpoint inhibitors (CPI) have recently extended the treatment options and improved clinical response of advanced stage head and neck squamous cell carcinoma (HNSCC), treatment success remains unpredictable. Programmed cell death ligand-1 (PD-L1) is a key player in immunotherapy. Tumor ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Affolter, Annette, Liebel, Kai, Tengler, Luisa, Seiz, Elena, Tiedtke, Moritz, Azhakesan, Alexya, Schütz, Julia, Theodoraki, Marie-Nicole, Kern, Johann, Ruder, Arne M., Fleckenstein, Jens, Weis, Cleo-Aron, Bieback, Karen, Kramer, Benedikt, Lammert, Anne, Scherl, Claudia, Rotter, Nicole, Ludwig, Sonja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552694/
https://www.ncbi.nlm.nih.gov/pubmed/37503786
http://dx.doi.org/10.3892/ijo.2023.5550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552694/
https://www.ncbi.nlm.nih.gov/pubmed/37503786
http://dx.doi.org/10.3892/ijo.2023.5550

Ejemplares similares